Form 8-K - Current report:
SEC Accession No. 0001824293-25-000042
Filing Date
2025-02-19
Accepted
2025-02-19 16:08:43
Documents
19
Period of Report
2025-02-19
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K val-20250219.htm   iXBRL 8-K 27530
2 EX-3.1 ex31_reversestocksplitchar.htm EX-3.1 9738
3 EX-99.1 ex991_pressreleasererevers.htm EX-99.1 13998
7 GRAPHIC charteramendment.jpg GRAPHIC 11066
8 GRAPHIC image_0.jpg GRAPHIC 38508
9 GRAPHIC val-20250219_g1.jpg GRAPHIC 16879
10 GRAPHIC val-20250219_g2.jpg GRAPHIC 1656
  Complete submission text file 0001824293-25-000042.txt   287220

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT val-20250219.xsd EX-101.SCH 1794
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT val-20250219_lab.xml EX-101.LAB 23493
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT val-20250219_pre.xml EX-101.PRE 13602
21 EXTRACTED XBRL INSTANCE DOCUMENT val-20250219_htm.xml XML 2920
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI Bio, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40034 | Film No.: 25640012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)